Concerns Regarding the Potential Drug Side Effects and Follow-Up Duration in the Study “Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting”: A Reply

  • Elnaz Javanshir Assistant Professor of Cardiology, Tabriz University of Medical Sciences, Cardiovascular Research Center, Madani Heart Center, Daneshgah Ave, Tabriz, Iran.
DOI: https://doi.org/10.18502/jthc.v19i1.18448

Abstract

The Abstract of the Article is not Available.

 
Published
2025-04-21
Issue
Volume (19) issue (1)
Section
Articles